Article

Multilayered validation of graph attention autoencoder–derived drug repurposing candidates for COVID-19

2026-07-02

Abstract excerpt

<title>Abstract</title> <p> <bold>Background/Objectives:</bold> The COVID-19 pandemic highlighted the critical need for drug repurposing to rapidly identify therapeutic options. While computational graph-based approaches show promise, conventional single analytical methods often fail to capture the complex pathological mechanisms needed for clinical translation. We aimed to prioritize COVID-19 repurposing candi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3d267fcd-012a-53e7-9f80-41adbb1ab786
DOI: 10.21203/rs.3.rs-8274293/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multilayered validation of graph attention autoencoder–derived drug repurposing candidates for COVID-19DOI 10.21203/rs.3.rs-8274293/v2Read

Novel graph attention autoencoder framework with multilayered validation identifies drug repurposing candidates for COVID-19 treatmentSemantic proximity Read

Repurposing Drugs for COVID-19 by Graph Convolutional NetworkSemantic proximity Read

Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological ValidationSemantic proximity Read

Identification of targets for drug repurposing to treat COVID-19 using a Deep Learning Neural NetworkSemantic proximity Read

Drug Target Set Enrichment Analysis (DTSEA): A Network-Based Approach for Drug Repurposing to COVID-19Semantic proximity Read

Drug repurposing for rare diseases via a gene-bridged heterogeneous knowledge graph and graph attention networkSemantic proximity Read

DeepDrug2: A Germline-focused Graph Neural Network Framework for Alzheimer’s Drug Repurposing Validated by Electronic Health RecordsSemantic proximity Read

DeepDrug: An Expert-led Domain-specific AI-Driven Drug-Repurposing Mechanism for Selecting the Lead Combination of Drugs for Alzheimer’s DiseaseSemantic proximity Read

A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19Semantic proximity Read

Network reinforcement driven drug repurposing for COVID-19 by exploiting disease-gene-drug associationsSemantic proximity Read

DR3E-Net: Drug Repurposing Network Framework Based on Deep Embedding, Differentially Expressed Genes, and Drug Side EffectsSemantic proximity Read

Network machine learning maps phytochemically-rich “Hyperfoods” to fight COVID-19Semantic proximity Read